Market Research Logo

Immune Repertoire Sequencing Market, by Product Type (Instruments, and Reagents and Kits), by Application (Cancer Immunotherapy, Infectious Disease, Asthma and Allergy, Biomarker Discovery, Organ Transplant, Immune Response, Autoimmune Diseases, and Other

Immune Repertoire Sequencing Market, by Product Type (Instruments, and Reagents and Kits), by Application (Cancer Immunotherapy, Infectious Disease, Asthma and Allergy, Biomarker Discovery, Organ Transplant, Immune Response, Autoimmune Diseases, and Others), by End User (Diagnostic Labs, Biopharmaceutical Companies, Research Institutes, and Others), and by Geography - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2017 -2025

Immune repertoire refers to sub-type protein that an organism’s immune system creates. Immune systems in vertebrates have six key types of proteins- two immunoglobulin and four T cell receptors. Immune repertoire sequencing enables researchers and scientists to examine and understand adaptive immune-mediated diseases. Immune repertoire sequencing is also widely applicable in biomarker discovery, infectious disease research, asthma and allergy research, and cancer immunotherapy.

Market Dynamics

Increasing prevalence of cancer worldwide is expected to boost immune repertoire sequencing market growth. According to National Cancer Institute, 2016, an estimated 16.8 million new cases of cancer were diagnosed in the U.S., with around 595,690 deaths from the disease. Moreover, the number of people suffering from cancer is expected to reach to 19 million by 2024. According to the Cancer Atlas, 2012, about 1.1 million new cancer cases and 600,000 cancer deaths are reported annually in Latin America and the Caribbean, where lung cancer is the leading cause of cancer death for both sexes.

However, factors such as high cost associated with certain sequencing platforms and data analytic services coupled with product recalls are expected to hinder growth of the immune repertoire sequencing market during the forecast period. For instance, in 2015, Illumina Inc. recalled its Illumina MiSeqDx Universal Kit 1.0, due to software limitation when using the product on MiSeqDx instrument. The software could not report insertions or deletions at specific genomic locations with respect to the primer.

Key features of the study:

  • This report provides in-depth analysis of the immune repertoire sequencing market, market size (US$ Mn), and Compound Annual Growth Rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2017 as the base year
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by leading players
  • It profiles key players in the global immune repertoire sequencing market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
  • Key players covered as a part of this study include Thermo Fisher Scientific, Inc., Illumina Inc., ArcherDX, Inc., Roche Holding AG, Pacific Biosciences, CD Genomics, Atreca, Inc., Adaptive Biotechnologies, Oxford Nanopore Technologies, Ltd., Qiagen N.V., Agilent Technologies, Inc., and Takara Bio, Inc.
  • Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global immune repertoire sequencing market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for immune repertoire sequencing market, research and consulting firms, new entrants, and financial analysts
Detailed Segmentation:
  • Global Immune Repertoire Sequencing Market, By Product Type:
  • Assay Kits
  • T-Cell Receptor (TCR) Kits
  • B-Cell Receptor (BCR) Kits
  • Instruments
  • Global Immune Repertoire Sequencing Market, By Application:
  • Cancer Immunotherapy
  • Biomarker Discovery
  • Autoimmune Diseases
  • Vaccine Development and Efficacy
  • Transplant Rejection and Tolerance
  • Infectious Diseases
  • Other Applications
  • Global Immune Repertoire Sequencing Market, By End User:
  • Diagnostic Labs
  • Biotechnology and Pharmaceutical Companies
  • Academic and Research Institutes
  • Others
  • Global Immune Repertoire Sequencing Market, By Region:
  • North America
  • By Country:
  • U.S.
  • Canada
  • By Product Type:
  • Assay Kits
  • T-Cell Receptor (TCR) Kits
  • B-Cell Receptor (BCR) Kits
  • Instruments
  • By Application:
  • Cancer Immunotherapy
  • Biomarker Discovery
  • Autoimmune Diseases
  • Vaccine Development and Efficacy
  • Transplant Rejection and Tolerance
  • Infectious Diseases
  • Other Applications
  • By End User:
  • Diagnostic Labs
  • Biotechnology and Pharmaceutical Companies
  • Academic and Research Institutes
  • Europe
  • By Country:
  • U.K.
  • Germany
  • Italy
  • Spain
  • France
  • Russia
  • Rest of Europe
  • By Product Type:
  • Assay Kits
  • T-Cell Receptor (TCR) Kits
  • B-Cell Receptor (BCR) Kits
  • Instruments
  • By Application:
  • Cancer Immunotherapy
  • Biomarker Discovery
  • Autoimmune Diseases
  • Vaccine Development and Efficacy
  • Transplant Rejection and Tolerance
  • Infectious Diseases
  • Other Applications
  • By End User:
  • Diagnostic Labs
  • Biotechnology and Pharmaceutical Companies
  • Academic and Research Institutes
  • Asia Pacific
  • By Country:
  • Australia
  • India
  • China
  • Japan
  • ASEAN
  • South Korea
  • Rest of Asia Pacific
  • By Product Type:
  • Assay Kits
  • T-Cell Receptor (TCR) Kits
  • B-Cell Receptor (BCR) Kits
  • Instruments
  • By Application:
  • Cancer Immunotherapy
  • Biomarker Discovery
  • Autoimmune Diseases
  • Vaccine Development and Efficacy
  • Transplant Rejection and Tolerance
  • Infectious Diseases
  • Other Applications
  • By End User:
  • Diagnostic Labs
  • Biotechnology and Pharmaceutical Companies
  • Academic and Research Institutes
  • Latin America
  • By Country:
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • By Product Type:
  • Assay Kits
  • T-Cell Receptor (TCR) Kits
  • B-Cell Receptor (BCR) Kits
  • Instruments
  • By Application:
  • Cancer Immunotherapy
  • Biomarker Discovery
  • Autoimmune Diseases
  • Vaccine Development and Efficacy
  • Transplant Rejection and Tolerance
  • Infectious Diseases
  • Other Applications
  • By End User:
  • Diagnostic Labs
  • Biotechnology and Pharmaceutical Companies
  • Academic and Research Institutes
  • Middle East
  • By Country:
  • GCC
  • Israel
  • Rest of Middle East
  • By Product Type:
  • Assay Kits
  • T-Cell Receptor (TCR) Kits
  • B-Cell Receptor (BCR) Kits
  • Instruments
  • By Application:
  • Cancer Immunotherapy
  • Biomarker Discovery
  • Autoimmune Diseases
  • Vaccine Development and Efficacy
  • Transplant Rejection and Tolerance
  • Infectious Diseases
  • Other Applications
  • By End User:
  • Diagnostic Labs
  • Biotechnology and Pharmaceutical Companies
  • Academic and Research Institutes
  • Africa
  • By Country:
  • South Africa
  • Central Africa
  • North Africa
  • By Product Type:
  • Assay Kits
  • T-Cell Receptor (TCR) Kits
  • B-Cell Receptor (BCR) Kits
  • Instruments
  • By Application:
  • Cancer Immunotherapy
  • Biomarker Discovery
  • Autoimmune Diseases
  • Vaccine Development and Efficacy
  • Transplant Rejection and Tolerance
  • Infectious Diseases
  • Other Applications
  • By End User:
  • Diagnostic Labs
  • Biotechnology and Pharmaceutical Companies
  • Academic and Research Institutes
  • Company Profiles
  • Thermo Fisher Scientific, Inc.*
  • Company Overview
  • Product Portfolio
  • Financial Performance
  • Recent Highlights
  • Strategies
  • Illumina Inc.
  • ArcherDX, Inc
  • Roche Holding AG
  • Pacific Biosciences
  • CD Genomics
  • Atreca, Inc.
  • Adaptive Biotechnologies
  • Oxford Nanopore Technologies, Ltd.
  • Qiagen N.V.
  • Agilent Technologies, Inc.
  • Takara Bio, Inc.
“*” marked represents similar segmentation in other categories in the respective section.


1. Research Objective and Assumption
Research Objectives
Assumptions
Abbreviations
2. Market Overview
Report Description
Market Definition and Scope
Executive Summary
Market Snippet, By Product Type
Market Snippet, By Application
Market Snippet, By End User
Market Snippet, By Region
Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
Market Dynamics
Drivers
Restraints
Market Opportunities
Impact Analysis
Market Trends
Key Developments
Regulatory Landscape
Product Recall
Epidemiology Analysis
Technology Overview
PEST Analysis
Porter’s Five Forces model
4. Global Immune Repertoire Sequencing Market, By Product Type, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Assay Kits
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
T-Cell Receptor (TCR) Kits
B-Cell Receptor (BCR) Kits
Instruments
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
5. Global Immune Repertoire Sequencing Market, By Application, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Cancer Immunotherapy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Biomarker Discovery
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Autoimmune Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Vaccine Development and Efficacy
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Transplant Rejection and Tolerance
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Infectious Diseases
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Other Applications
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
6. Global Immune Repertoire Sequencing Market, By End User, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, 2018 and 2026 (%)
Y-o-Y Growth Analysis, 2017 – 2026
Segment Trends
Diagnostic Labs
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Biotechnology and Pharmaceutical Companies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Academic and Research Institutes
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2018 – 2026, (US$ Million)
7. Global Immune Repertoire Sequencing Market, By Region, 2018 – 2026, (US$ Million)
Introduction
Market Share Analysis, By Region, 2018 and 2026 (%)
Y-o-Y Growth Analysis, By Region, 2017 – 2026
Regional Trends
North America
Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Application, 2018 – 2026, (US$ Million)
Market Size and Forecast, By End User, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
U.S.
Canada
Europe
Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Application, 2018 – 2026, (US$ Million)
Market Size and Forecast, By End User, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Application, 2018 – 2026, (US$ Million)
Market Size and Forecast, By End User, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
China
Japan
India
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Application, 2018 – 2026, (US$ Million)
Market Size and Forecast, By End User, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
Brazil
Mexico
Argentina
Rest of Latin America
Africa
Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Application, 2018 – 2026, (US$ Million)
Market Size and Forecast, By End User, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
North Africa
Central Africa
South Africa
Middle East
Market Size and Forecast, By Product Type, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Application, 2018 – 2026, (US$ Million)
Market Size and Forecast, By End User, 2018 – 2026, (US$ Million)
Market Size and Forecast, By Country, 2018 – 2026, (US$ Million)
GCC Countries
Israel
Rest of Middle East
8. Competitive Landscape
Company Profiles
Thermo Fisher Scientific, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Illumina Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
ArcherDX, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Roche Holding AG
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Pacific Biosciences
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
CD Genomics
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Atreca, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Adaptive Biotechnologies
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Oxford Nanopore Technologies, Ltd.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Qiagen N.V.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Agilent Technologies, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Takara Bio, Inc.
Company Overview
Product Portfolio
Financial Performance
Recent Highlights
Strategies
Analyst Views
9. Section
References
Research Methodology
About Us and Sales Contact
*Browse 38 market data tables and 27 figures on "Immune Repertoire Sequencing Market” - Global forecast to 2026”

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook